Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ocugen, Inc.
  6. News
  7. Summary
    OCGN   US67577C1053

OCUGEN, INC.

(OCGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Social Buzz: Ocugen, Nokia Leading Wallstreetbets Winners; MicroVision, GameStop Fall

05/03/2021 | 03:58pm EDT


© MT Newswires 2021
All news about OCUGEN, INC.
06/18OCUGEN ALERT : Bragar Eagel & Squire, P.C. Is Investigating Ocugen, Inc. on Beha..
BU
06/18OCUGEN  : ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors W..
PR
06/18SHAREHOLDER ACTION ALERT : The Schall Law Firm Reminds Investors of a Class Acti..
BU
06/18INVESTOR ALERT : Law Offices of Howard G. Smith Announces the Filing of a Securi..
BU
06/18OCUGEN  : Notice of Lead Plaintiff Deadline for Shareholders in the Ocugen, Inc...
BU
06/18Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
GL
06/16GLANCY PRONGAY & MURRAY LLP  : a Leading Securities Fraud Law Firm, Announces In..
BU
06/16THE LAW OFFICES OF FRANK R. CRUZ  : Announces Investigation of Ocugen, Inc. (OCG..
BU
06/16INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Ocuge..
BU
06/16OCUGEN  : to Join Russell 3000 Index
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -25,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -54,8x
Yield 2021 -
Capitalization 1 302 M 1 302 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 12,7x
Nbr of Employees 15
Free-Float 97,4%
Chart OCUGEN, INC.
Duration : Period :
Ocugen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OCUGEN, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 6,13 $
Last Close Price 6,57 $
Spread / Highest target 52,2%
Spread / Average Target -6,77%
Spread / Lowest Target -39,1%
EPS Revisions
Managers and Directors
NameTitle
Shankar Musunuri Chairman & Chief Executive Officer
Sanjay Subramanian CFO, Secretary & Head-Corporate Development
Arun Upadhyay Vice President-Research & Development
Bruce D. Forrest Chief Medical Officer
Uday B. Kompella Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
OCUGEN, INC.257.38%1 302
MODERNA, INC.90.67%79 980
LONZA GROUP LTD14.63%52 508
IQVIA HOLDINGS INC.33.76%45 934
CELLTRION, INC.-24.79%32 465
SEAGEN INC.-10.75%28 367